Viñuela-Berni et al. also demonstrated an increase in circulating EVs in SLE and RA and that these EVs could potently stimulate the release of interleukin 17 (IL-17), TNF-α, and interleukin 1 (IL-1) in vitro [74]. This evidence concerns the gene IL17A and systemic lupus erythematosus.